Reports for MINT PHARMACEUTICALS INC
Company Name
MINT PHARMACEUTICALS INC
Shortage reports
Actual shortage:
23 (15%)
Anticipated shortage:
0 (0%)
Avoided shortage:
1 (1%)
Resolved:
125 (84%)
149
Discontinuation Reports
To be discontinued:
0 (0%)
Discontinued:
29 (100%)
Reversed:
0 (0%)
29
34 (19%)
17 (74%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MINT-ROSUVASTATIN | 10MG | TABLET | Resolved | 2019-01-03 | 2019-02-01 | 71081 |
| MINT-ROSUVASTATIN | 20MG | TABLET | Resolved | 2019-01-03 | 2019-02-01 | 71087 |
| MINT-ROSUVASTATIN | 20MG | TABLET | Resolved | 2019-08-22 | 2024-12-05 | 92275 |
| MINT-ROSUVASTATIN | 20MG | TABLET | Actual shortage | 2025-03-18 | 2025-07-31 | 252956 |
| MINT-ROSUVASTATIN | 40MG | TABLET | Actual shortage | 2025-03-18 | 2025-07-31 | 252959 |
| MINT-SERTRALINE | 25MG | CAPSULE | Resolved | 2018-01-09 | 2018-03-09 | 35483 |
| MINT-SIMVASTATIN | 20MG | TABLET | Resolved | 2019-10-09 | 2019-11-17 | 95932 |
| MINT-SIMVASTATIN | 80MG | TABLET | Resolved | 2018-01-09 | 2018-02-15 | 35489 |
| MINT-SIMVASTATIN | 80MG | TABLET | Resolved | 2019-10-09 | 2019-11-17 | 95938 |
| MINT-SIMVASTATIN | 40MG | TABLET | Resolved | 2019-10-09 | 2019-11-17 | 95935 |
| MINT-SIMVASTATIN | 5MG | TABLET | Resolved | 2019-10-09 | 2019-11-17 | 95927 |
| MINT-SIMVASTATIN | 5MG | TABLET | Resolved | 2018-01-09 | 2018-02-15 | 35486 |
| MINT-SOLIFENACIN | 10MG | TABLET | Resolved | 2018-01-09 | 2018-03-21 | 35495 |
| MINT-SOLIFENACIN | 5MG | TABLET | Resolved | 2018-01-09 | 2018-03-21 | 35492 |
| MINT-SPIRONOLACTONE | 100MG | TABLET | Resolved | 2021-01-11 | 2021-04-05 | 131333 |
| MINT-SPIRONOLACTONE | 100MG | TABLET | Actual shortage | 2025-07-08 | 2026-03-17 | 262196 |
| MINT-SPIRONOLACTONE | 100MG | TABLET | Resolved | 2022-09-19 | 2023-03-13 | 169555 |
| MINT-SPIRONOLACTONE | 25MG | TABLET | Actual shortage | 2025-07-08 | 2026-03-17 | 262193 |
| MINT-SPIRONOLACTONE | 25MG | TABLET | Resolved | 2022-09-19 | 2023-03-13 | 169552 |
| MINT-TOPIRAMATE | 100MG | TABLET | Resolved | 2024-01-29 | 2024-12-05 | 217684 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MINT-CITALOPRAM | 20MG | TABLET | Discontinued | 2023-05-02 | 2023-05-03 | 191439 |
| MINT-CITALOPRAM | 40MG | TABLET | Discontinued | 2023-05-02 | 2023-05-03 | 191442 |
| MINT-CLOPIDOGREL | Discontinued | 2019-02-04 | 2019-02-05 | 74442 | ||
| MINT-CLOPIDOGREL | Discontinued | 2019-02-04 | 2019-02-05 | 74435 | ||
| MINT-CLOPIDOGREL | 75MG | TABLET | Discontinued | 2018-08-16 | 2018-08-17 | 58286 |
| MINT-CLOPIDOGREL | 75MG | TABLET | Discontinued | 2018-08-16 | 2018-08-17 | 58283 |
| MINT-DORZOLAMIDE/TIMOLOL | 5MG 20MG | SOLUTION | Discontinued | 2019-06-04 | 2019-06-04 | 85525 |
| MINT-FENOFIBRATE E | 145MG | TABLET | Discontinued | 2020-04-25 | 2020-04-25 | 113175 |
| MINT-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2021-08-11 | 2021-08-11 | 143959 |
| MINT-IRBESARTAN/HCTZ | 12.5MG 300MG | TABLET | Discontinued | 2021-08-11 | 2021-08-11 | 143952 |
| MINT-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2021-08-11 | 2021-08-11 | 143956 |
| MINT-LEVOFLOXACIN | 250MG | TABLET | Discontinued | 2022-10-02 | 2022-10-03 | 170853 |
| MINT-LEVOFLOXACIN | 750MG | TABLET | Discontinued | 2022-10-02 | 2022-10-03 | 170859 |
| MINT-LEVOFLOXACIN | 500MG | TABLET | Discontinued | 2022-10-02 | 2022-10-03 | 170856 |
| MINT-METFORMIN | 500MG | TABLET | Discontinued | 2019-07-04 | 2019-07-05 | 88513 |
| MINT-METFORMIN | 850MG | TABLET | Discontinued | 2020-03-09 | 2020-03-10 | 108292 |
| MINT-RIVASTIGMINE | 3MG | CAPSULE | Discontinued | 2017-06-21 | 2017-07-01 | 13556 |
| MINT-RIVASTIGMINE | 6MG | CAPSULE | Discontinued | 2017-06-21 | 2017-07-01 | 13559 |
| MINT-RIVASTIGMINE | 4.5MG | CAPSULE | Discontinued | 2017-06-21 | 2017-07-01 | 13565 |
| MINT-RIVASTIGMINE | 1.5MG | CAPSULE | Discontinued | 2017-06-21 | 2017-07-01 | 13562 |